PDCD1 and neoplasm: Our in vitro assay showed that BGB-A317/IgG4S228P induced significant ADCP than BGB-A317, raising the possibility that FcγRI binding might lead to the killing of PD-1+ TILs by TAMs and inferior anti-tumor activity.